Search Results - "SUDDATH, William O"

A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome by Waksman, Ron, MD, Torguson, Rebecca, MPH, Kent, Kenneth M., MD, PhD, Pichard, Augusto D., MD, Suddath, William O., MD, Satler, Lowell F., MD, Martin, Brenda D., RN, Perlman, Timothy J., BSME, Maltais, Jo-Ann B., PhD, Weissman, Neil J., MD, Fitzgerald, Peter J., MD, Brewer, H. Bryan, MD

“…Objectives This study aimed to determine whether serial autologous infusions of selective high-density lipoprotein (HDL) delipidated plasma are feasible and…”
Get full text

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy by McFadden, Eugène P, Stabile, Eugenio, Regar, Evelyn, Cheneau, Edouard, Ong, Andrew TL, Kinnaird, Timothy, Suddath, William O, Weissman, Neil J, Torguson, Rebecca, Kent, Kenneth M, Pichard, August D, Satler, Lowell F, Waksman, Ron, Serruys, Patrick W

“…Although the safety profiles of coronary stents eluting sirolimus or paclitaxel do not seem to differ from those of bare metal stents in the short-to-medium…”
Get full text

Impact of “Nuisance” Bleeding on Clopidogrel Compliance in Patients Undergoing Intracoronary Drug-Eluting Stent Implantation by Roy, Probal, MD, Bonello, Laurent, MD, Torguson, Rebecca, MPH, de Labriolle, Axel, MD, Lemesle, Gilles, MD, Slottow, Tina L. Pinto, MD, Steinberg, Daniel H., MD, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Suddath, William O., MD, Pichard, Augusto D., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Premature cessation of clopidogrel is a strong risk factor for drug-eluting stent thrombosis in patients undergoing percutaneous coronary intervention. The…”
Get full text

Clinical Profile, Prognostic Implication, and Response to Treatment of Pulmonary Hypertension in Patients With Severe Aortic Stenosis by Ben-Dor, Itsik, MD, Goldstein, Steven A., MD, Pichard, Augusto D., MD, Satler, Lowell F., MD, Maluenda, Gabriel, MD, Li, Yanlin, MD, Syed, Asmir I., MD, Gonzalez, Manuel A., MD, MPH, Gaglia, Michael A., MD, MSc, Wakabayashi, Kohei, MD, Delhaye, Cedric, MD, Belle, Loic, MD, Wang, Zuyue, MD, Collins, Sara D., MD, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Aderotoye, Adefolaseyi, MS, Xue, Zhenyi, MS, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Epstein, Stephen E., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…The incidence, correlates, and prognostic implications of pulmonary hypertension (PH) are unclear in patients with severe aortic stenosis (AS). We studied 509…”
Get full text

Impact of Previous Coronary Artery Bypass Grafting on Patients Undergoing Transcatheter Aortic Valve Implantation for Aortic Stenosis by Minha, Sa'ar, MD, Magalhaes, Marco A., MD, Barbash, Israel M., MD, Ben-Dor, Itsik, MD, Dvir, Danny, MD, Okubagzi, Petros G., MD, Chen, Fang, PhD, Torguson, Rebecca, MPH, Kent, Kenneth M., MD, PhD, Suddath, William O., MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Re-operation after coronary artery bypass grafting (CABG) is associated with increased risk for morbidity and mortality. Transcatheter aortic valve…”
Get full text

Frequency of Angina Pectoris After Percutaneous Coronary Intervention and the Effect of Metallic Stent Type by Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Lipinski, Michael J., MD, PhD, Gai, Jiaxiang, MSPH, Koifman, Edward, MD, Kiramijyan, Sarkis, MD, Negi, Smita, MD, Rogers, Toby, MD, Steinvil, Arie, MD, Suddath, William O., MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Although metallic coronary stents significantly reduce angina pectoris compared with optimal medical therapy, angina after percutaneous coronary intervention…”
Get full text

Management and Outcomes of Coronary Artery Perforation During Percutaneous Coronary Intervention by Javaid, Aamir, Buch, Ashesh N., Satler, Lowell F., Kent, Kenneth M., Suddath, William O., Lindsay, Joseph, Pichard, Augusto D., Waksman, Ron

“…Coronary perforation is a particularly feared complication of percutaneous coronary intervention. The optimal management and predictors of adverse outcomes for…”
Get full text

Racial disparity with on-treatment platelet reactivity in patients undergoing percutaneous coronary intervention by Pendyala, Lakshmana K., MD, Torguson, Rebecca, MPH, Loh, Joshua P., MBBS, Devaney, Joseph M., PhD, Chen, Fang, PhD, Kitabata, Hironori, MD, Minha, Sa’ar, MD, Barbash, Israel M., MD, Suddath, William O., MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Background On-treatment platelet reactivity to clopidogrel is variable and in part genetic dependent. In African American (AA) patients, the relation between…”
Get full text

Relation of Proton Pump Inhibitor Use After Percutaneous Coronary Intervention With Drug-Eluting Stents to Outcomes by Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Hanna, Nicholas, MD, Gonzalez, Manuel A., MD, MPH, Collins, Sara D., MD, Syed, Asmir I., MD, Ben-Dor, Itsik, MD, Maluenda, Gabriel, MD, Delhaye, Cedric, MD, Wakabayashi, Kohei, MD, Xue, Zhenyi, MS, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Recent evidence has shown that clopidogrel and proton pump inhibitors (PPIs) are metabolized by the same pathway and that patients taking both drugs have…”
Get full text

Two-Year Follow-Up of Outcomes of Second-Generation Everolimus-Eluting Stents Versus First-Generation Drug-Eluting Stents for Stenosis of Saphenous Vein Grafts Used as Aortocoronary Conduits by Kitabata, Hironori, MD, PhD, Loh, Joshua P., MBBS, Pendyala, Lakshmana K., MD, Badr, Salem, MD, Dvir, Danny, MD, Barbash, Israel M., MD, Minha, Sa'ar, MD, Torguson, Rebecca, MPH, Chen, Fang, MS, PhD, Satler, Lowell F., MD, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Second-generation everolimus-eluting stents (EESs) have demonstrated superiority in efficacy and safety compared with first-generation drug-eluting stents…”
Get full text

Outcome Differences With the Use of Drug-Eluting Stents for the Treatment of In-Stent Restenosis of Bare-Metal Stents Versus Drug-Eluting Stents by Steinberg, Daniel H., MD, Gaglia, Michael A., MD, MSc, Pinto Slottow, Tina L., MD, Roy, Probal, MD, Bonello, Laurent, MD, De Labriolle, Axel, MD, Lemesle, Gilles, MD, Torguson, Rebecca, MPH, Kineshige, Kimberly, BS, Xue, Zhenyi, MD, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Drug-eluting stent (DES) implantation is the standard treatment for patients with bare-metal stent (BMS) in-stent restenosis (ISR) and is associated with low…”
Get full text

Role of Prophylactic Intra-Aortic Balloon Pump in High-Risk Patients Undergoing Percutaneous Coronary Intervention by Mishra, Sundeep, Chu, William W., Torguson, Rebecca, Wolfram, Roswitha, Deible, Regina, Suddath, William O., Pichard, Augusto D., Satler, Lowell F., Kent, Kenneth M., Waksman, Ron

“…Intra-aortic balloon pump (IABP) has been shown to support patients who are at high risk for percutaneous coronary interventions (PCIs) or becoming…”
Get full text

Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound by Maehara, Akiko, Mintz, Gary S., Bui, Anh B., Walter, Olga R., Castagna, Marco T., Canos, Daniel, Pichard, August D., Satler, Lowell F., Waksman, Ron, Suddath, William O., Laird, John R., Kent, Kenneth M., Weissman, Neil J.

“…This study was designed to report the clinical and angiographic correlates of plaque rupture detected by intravascular ultrasound (IVUS). Acute coronary…”
Get full text

Safety and Efficacy of the XIENCE V Everolimus-Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice by Waksman, Ron, MD, Barbash, Israel M., MD, Dvir, Danny, MD, Torguson, Rebecca, MPH, Ben-Dor, Itsik, MD, Maluenda, Gabriel, MD, Xue, Zhenyi, MD, Satler, Lowell F., MD, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Pichard, Augusto D., MD

“…Data from randomized clinical trials have shown the safety and efficacy of the XIENCE V in selected populations. However, limited data are available comparing…”
Get full text

Can Acute Occlusion of the Left Anterior Descending Coronary Artery Produce a Typical “Takotsubo” Left Ventricular Contraction Pattern? by Chao, Tania, MD, Lindsay, Joseph, MD, Collins, Sara, MD, Woldeyes, Libay, MD, Joshi, Subodh B., MD, Steinberg, Daniel H., MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, Suddath, William O., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…The takotsubo syndrome (TS) takes its name from a distinctive left ventricular (LV) contraction abnormality. Patients with this disorder present with clinical…”
Get full text

Association Between Bleeding Severity and Long-Term Mortality in Patients Experiencing Vascular Complications After Percutaneous Coronary Intervention by Romaguera, Rafael, MD, Wakabayashi, Kohei, MD, Laynez-Carnicero, Ana, MD, Sardi, Gabriel, MD, Maluenda, Gabriel, MD, Ben-Dor, Itsik, MD, Torguson, Rebecca, MPH, Kent, Kenneth M., MD, Satler, Lowell F., MD, Suddath, William O., MD, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Vascular complications (VCs) occur in 3% to 8% of percutaneous coronary interventions (PCIs). However, only a portion of patients who experience VCs bleed…”
Get full text

Impact of Chronic Obstructive Pulmonary Disease on Acute-Phase Outcome of Myocardial Infarction by Wakabayashi, Kohei, MD, Gonzalez, Manuel A., MD, MPH, Delhaye, Cedric, MD, Ben-Dor, Itsik, MD, Maluenda, Gabriel, MD, Collins, Sara D., MD, Syed, Asmir I., MD, Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Xue, Zhenyi, MS, Suddath, William O., MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Several reports have alluded to the adverse effect of chronic obstructive pulmonary disease (COPD) on long-term prognosis of patients with myocardial…”
Get full text

Safety of Reloading Prasugrel in Addition to Clopidogrel Loading in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention by Loh, Joshua P., MBBS, Pendyala, Lakshmana K., MD, Kitabata, Hironori, MD, PhD, Torguson, Rebecca, MPH, Chen, Fang, PhD, Kent, Kenneth M., MD, PhD, Satler, Lowell F., MD, Suddath, William O., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI) commonly receive a loading dose of either clopidogrel or prasugrel,…”
Get full text

Comparison of Safety, Efficacy, and Outcome of Successful Versus Unsuccessful Percutaneous Coronary Intervention in “True” Chronic Total Occlusions by de Labriolle, Axel, MD, Bonello, Laurent, MD, Roy, Probal, MBBS, Lemesle, Gilles, MD, Steinberg, Daniel H., MD, Xue, Zhenyi, MS, Kaneshige, Kimberly, BS, Suddath, William O., MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Pichard, Augusto D., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Despite improving techniques for opening chronic total occlusions (CTOs), the benefit of successful recanalization of the artery remains unclear. The aims of…”
Get full text

Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era? by COLLINS, Sara D, TORGUSON, Rebecca, KENT, Kenneth M, PICHARD, Augusto D, SUDDATH, William O, SATLER, Lowell F, WAKSMAN, Ron, GAGLIA, Michael A, LEMESLE, Gilles, SYED, Asmir I, BEN-DOR, Itsik, YANLIN LI, MALUENDA, Gabriel, KANESHIGE, Kimberly, ZHENYI XUE

“…It has been suggested that black race predicts stent thrombosis (ST) after drug-eluting stent implantation. Whether socioeconomic status or comorbid conditions…”
Get full text